Abstract: There is provided a method of judging a risk of cancer recurrence based on the activity value and expression level of the first CDK, the activity value and expression level of the second CDK, and the expression levels of uPA and PAI-1 and a computer program.

Abstract: A sample analyzer comprises a sample analysis unit which analyzes a sample, a reading unit which reads information from a storage medium attached to a container that contains a quality control sample, a display, and a controller which displays on the display an analysis result obtained by another sample analyzer and read from the storage medium and an analysis result obtained by the sample analysis unit, when the storage medium stores the analysis result obtained by the other sample analyzer.

Abstract: Provided is a canceration information providing method capable of presenting information related to canceration of cells with high reliability. A cell in which an amount of DNA is greater than or equal to an amount of DNA of a normal cell in a S period is extracted from a cell group of V11?N/C ratio?V12 (first counting step). If a number of cells obtained in the first counting step is greater than or equal to a threshold value S1 (S107: YES), “Cancer” is set to a flag 1. A cell in which an amount of DNA is 2C is extracted from a cell group of V13?N/C ratio<V11 (second counting step). A ratio of a number of cells obtained in the first counting step and a number of cells obtained in the second counting step is calculated, and “Cancer” is set to a flag 2 if the ratio is greater than or equal to a threshold value S2 (S111: YES). If either one of the flags 1, 2 is “Cancer” (S113: YES), retest necessary is displayed.

Abstract: Provided is a canceration information providing method capable of presenting the information related to canceration of the cells with high reliability. A cell in which the amount of DNA is greater than or equal to the amount of DNA of the normal cell in the S period is extracted from a cell group of V11?N/C ratio?V12 (first counting step). If the number of cells obtained in the first counting step is greater than or equal to the threshold value S1 (S107: YES), “Cancer” is set to a flag 1. A cell in which the amount of DNA is 2C is extracted from a cell group of V13?N/C ratio?V11 (second counting step). A ratio of the number of cells obtained in the second counting step and number of cells obtained in the first counting step is calculated, and “Cancer” is set to a flag 2 if the ratio is greater than or equal to a threshold value S2 (S111: YES). If one of the flags 1, 2 is “Cancer” (S113: YES), the display of retest necessary is performed.

Abstract: The present invention provides a cell analyzer which comprises: a cell dispersion unit which causes aggregated cells in a biological specimen to be dispersed, through a shearing force applying process of applying a shearing force to the aggregated cells and an ultrasonic dispersion process of dispersing the aggregated cells, by using ultrasonic waves; a detection unit which detects characteristics information reflecting properties of the cells in the biological specimen on which the shearing force applying process and the ultrasonic dispersion process have been performed; and an analysis unit which analyzes the cells in the biological specimen, based on a detection result from the detection unit.

Abstract: Herewith disclosed is a sample analyzer comprising: a measurement section configured to perform a measurement on a sample and generate a measurement value according to the concentration of an analyte in the sample; a memory storing a calibration curve; an analysis section; an output section; and an instruction receiver. When the instruction receiver receives an instruction to perform a diluting measurement on a calibration sample, the measurement section dilutes the calibration sample by a predetermined ratio and performs a measurement on the diluted calibration sample, and the analysis section determines the concentration of the analyte in the diluted calibration sample by applying a measurement value obtained from the diluted calibration sample to the calibration curve. Information generated based on the determined concentration and the known concentration is output.

Abstract: A method for predicting differentiation-inducing properties of naive T-cells to regulatory T-cells comprising: measuring an amount of ZAK in naive T-cells contained in the body fluid collected from the living body; and predicting differentiation-inducing properties of the naive T-cells to regulatory T-cells based on the measurement results is disclosed. A method for determining the risk of development of Graft versus Host Disease and a biomarker for predicting differentiation-inducing properties of naive T-cells to regulatory T-cells are also disclosed.

Abstract: A method for detecting adrenocorticotropic hormone comprising: bringing a liquid sample containing adrenocorticotropic hormone into contact with gelled casein to adsorb adrenocorticotropic hormone to the gelled casein; and detecting the adrenocorticotropic hormone adsorbed to the gelled casein is disclosed. An adsorbent of adrenocorticotropic hormone comprising gelled casein is also disclosed.

Abstract: An analyzer comprises a dispenser which dispenses a liquid into a container, a detector which comprises a phototransmitter which emits light to the container and a photoreceiver which receives light from the phototransmitter, a moving unit which changes a relative position between the container and the detector, and a controller which determines whether an amount of the liquid in the container is within a predetermined range, based on outputs from the detector at a plurality of the relative positions.

Abstract: The present invention is a blood cell analyzer. When only measuring one or more measurement items included in one group, a first sample supplying operation is performed which includes aspirating a blood sample by a first amount. When measuring one or more measurement items included in the one group and another measurement item not included in the one group, a second sample supplying operation and a third sample supplying operation are performed. The second sample supplying operation includes aspirating the blood sample by the first amount for the measurement items included in the one group, and the third sample supplying operation includes aspirating the blood sample by a second amount for the another measurement item.

Abstract: A sample processing apparatus is disclosed. The apparatus comprises a sample processing section configured to perform a process on a sample; and a controller configured to execute an order defining a process to be performed on a sample and to cause the sample processing section to perform the process on the sample according to the order. When the controller receives an instruction to perform a shutdown operation, the controller performs the following operations comprising: prohibiting the execution of the shutdown operation if an unexecuted order remains; and causing the sample processing section to perform the shutdown operation if there is no unexecuted order.

Abstract: The present invention relates to novel diagnostic markers for kidney disease and the use thereof.

Abstract: The present invention relates to a reagent for the measurement of FDP comprising a carrier sensitized with at least two monoclonal antibodies selected from three monoclonal antibodies having different reactivity towards FDP. The present invention also relates to a reagent kit comprising the reagent and a method for measurement of FDP using the reagent or reagent kit.

Abstract: Provided is a sample processing apparatus management system, sample processing apparatuses and a management apparatus, and a management method that can accurately and easily adjust the respective sample processing apparatuses irrespective of their individual differences. When abnormality has occurred in a sample analyzer, the sample analyzer requests approval for self-adjustment from a management server. The management server determines whether to permit performance of the self-adjustment, and when having determined to permit the self-adjustment, notifies the sample analyzer of the approval for the self-adjustment. When the approval for the self-adjustment has been notified of, the sample analyzer performs the self-adjustment.

Abstract: A blood cell counter comprises a stirrer which stirs a whole blood sample in a sample container by moving the sample container, an aspirator which aspirates the whole blood sample by penetrating a lid of the sample container with an aspiration tube after stirring by the stirrer, a detector which counts the blood cells in the whole blood sample aspirated by the aspirator, and a force applying member which applies a force to the sample container in an upright state after stirring by the stirrer so as to remove the whole blood sample from the lid of the sample container.

Abstract: An analyzer comprising: a first measurement unit for measuring samples; a second measurement unit; and a transportation device operable to transport a plurality of sample containers accommodated in a first rack and containing samples and a plurality of sample containers accommodated in a second rack and containing samples, to the first measurement unit and the second measurement unit, wherein the transportation device comprises a first transportation section operable to transport the plurality of sample containers on the first rack to the first measurement unit and the second measurement unit by transporting the first rack on a transport path, and a second transportation section operable to transport the plurality of sample containers on the second rack to the first measurement unit and the second measurement unit by transporting the second rack on the transport path independently from movement of the first rack, is disclosed. A transportation device is also disclosed.

Abstract: A sample analyzer includes a first measurement unit, a second measurement unit, a detection section which detects information about an amount of a sample in a sample container before the first measurement unit aspirates the sample in the sample container, and a control section. Based on a detection result by the detection section and based on information about a predetermined sample amount necessary for performing both in the first measurement unit and the second measurement unit, when the control section has determined that the amount of the sample in the sample container is insufficient for the predetermined sample amount, the control section controls the first measurement unit and the second measurement unit so as not to aspirate the sample in the sample container.

Abstract: To provide a detection method of activated neutrophils enabling the classification of normal leukocytes and the detection of activated neutrophils, a measurement sample in which erythrocytes in a biotic sample are hemolyzed and nucleic acid of leukocytes is stained by a nucleic acid staining fluorochrome is prepared, the sample is irradiated with light, and leukocytes in the biotic sample are classified into at least a cluster containing neutrophils and a cluster containing eosinophils based on scattered light intensity and fluorescence intensity obtained by measuring the scattered light intensity and fluorescence intensity generated from particles in the sample to detect particles present between the cluster containing neutrophils and the cluster containing eosinophils as activated neutrophils.

Abstract: A glucose tolerance analyzer comprising: an accepting section configured to accept inputs of information regarding a type of food or drink ingested by a subject, information regarding an intake amount of the food or drink, and information regarding an amount of glucose in the subject after the ingestion of the food or drink; an output section configured to output an analysis result of glucose tolerance; and a controller configured to: calculate a reference value for analyzing glucose tolerance of the subject based on the accepted information regarding the type of the food or drink ingested by the subject and the information regarding the intake amount of the food or drink, and based on a predetermined index regarding blood glucose increase due to food or drink; analyze the glucose tolerance of the subject based on the accepted information regarding the amount of glucose and based on the calculated reference value; and control the output section to output an obtained analysis result as an analysis result of gl

Abstract: A sample processing apparatus comprises a sample processing unit for processing a sample, a control unit for accepting a stop instruction to stop the operation of the sample processing unit, and an output unit. The control unit is configured to control the output unit to output consumable good information related to lack of the consumable good that occurs if the consumable good runs out before completion of next starting of the sample processing unit when accepting the stop instruction.